Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGT.L Regulatory News (SIGT)

  • There is currently no data for SIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Seneca Global Income & Grwth

29 Nov 2016 12:02

RNS Number : 4461Q
Seneca Global Income & Growth PLC
29 November 2016
 

 

London, UK, 29 November 2016

Edison issues research review on Seneca Global Income & Growth Trust (SIGT)

 

Seneca Global Income & Growth Trust (SIGT) aims to generate income and long-term capital growth from a range of asset classes. Investments are made for the long term using a strategic asset allocation to equities (60%: 35% UK and 25% overseas, with modest US exposure), fixed income (15%) and specialist assets (25%, including property and infrastructure assets, where yields can be in the 5-8% range). Around one-third of the fund is invested in UK mid-caps, where over time returns tend to be higher than for large-caps, and where the market is generally less efficient, providing opportunities for stock picking. There is no exposure to safe-haven government bonds, which the managers consider unattractively valued, and SIGT has lower FX exposure than its peers. Following a change in investment mandate in 2012, SIGT's NAV total return has meaningfully outperformed the FTSE All-Share index, with significantly lower volatility.

 

SIGT's current 1.8% share price premium to cum-income NAV compares to the average 0.6% premium of the last 12 months and the average discounts of the last three, five and 10 years (3.2%, 6.4% and 7.2%, respectively). While SIGT has no formal income target, the board states that it wants to pursue a progressive dividend policy. The annual dividend has been increased each year since 2013; the prospective dividend yield is 3.8%.

Click here to view the full report

 

All reports published by Edison are available to download free of charge from its website: www.edisoninvestmentresearch.com

 

About Edison: Edison is an international equity research firm with a team of over 70 analysts, investment and roadshow professionals and works with both large and smaller capitalised companies, blue chip institutional investors, wealth managers, private equity and corporate finance houses to support their capital markets activity. Edison provides services to more than 420 retained corporate and investor clients from offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority.

 

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

Contact details: Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn

www.linkedin.com/company/edison-investment-research

Twitter

www.twitter.com/Edison_Inv_Res

YouTube

www.youtube.com/edisonitv

Google+

https://plus.google.com/105425025202328783163/posts

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKLFLQFFEFBV
Date   Source Headline
7th Feb 202011:49 amRNSNet Asset Value(s)
6th Feb 202012:03 pmRNSNet Asset Value(s)
5th Feb 202011:40 amRNSNet Asset Value(s)
4th Feb 202011:23 amRNSNet Asset Value(s)
3rd Feb 202012:44 pmRNSNet Asset Value(s)
3rd Feb 202010:36 amRNSTotal Voting Rights
31st Jan 202011:25 amRNSNet Asset Value(s)
30th Jan 202011:20 amRNSNet Asset Value(s)
29th Jan 202010:50 amRNSNet Asset Value(s)
28th Jan 202011:00 amRNSNet Asset Value(s)
27th Jan 202012:00 pmRNSNet Asset Value(s)
24th Jan 202011:33 amRNSNet Asset Value(s)
23rd Jan 202011:50 amRNSNet Asset Value(s)
22nd Jan 202011:18 amRNSNet Asset Value(s)
21st Jan 20202:35 pmRNSNet Asset Value(s)
20th Jan 202012:25 pmRNSNet Asset Value(s)
17th Jan 202012:11 pmRNSNet Asset Value(s)
16th Jan 202010:56 amRNSNet Asset Value(s)
15th Jan 202011:36 amRNSNet Asset Value(s)
14th Jan 202010:49 amRNSNet Asset Value(s)
13th Jan 20204:17 pmRNSIssue of Equity
13th Jan 202011:06 amRNSNet Asset Value(s)
10th Jan 20204:41 pmRNSIssue of Equity
10th Jan 202010:49 amRNSNet Asset Value(s)
9th Jan 20204:28 pmRNSIssue of Equity
9th Jan 202010:44 amRNSNet Asset Value(s)
8th Jan 202011:16 amRNSNet Asset Value(s)
7th Jan 202011:18 amRNSNet Asset Value(s)
6th Jan 20204:20 pmRNSIssue of Equity
6th Jan 20201:40 pmRNSNet Asset Value(s)
3rd Jan 20204:28 pmRNSIssue of Equity
3rd Jan 202011:21 amRNSNet Asset Value(s)
2nd Jan 202010:57 amRNSNet Asset Value(s)
2nd Jan 20209:38 amRNSTotal Voting Rights
31st Dec 201910:09 amRNSNet Asset Value(s)
30th Dec 201910:34 amRNSNet Asset Value(s)
27th Dec 201910:46 amRNSNet Asset Value(s)
24th Dec 201910:52 amRNSNet Asset Value(s)
23rd Dec 201912:01 pmRNSNet Asset Value(s)
23rd Dec 20198:37 amRNSBlock listing Interim Review
20th Dec 201911:18 amRNSNet Asset Value(s)
19th Dec 201910:42 amRNSNet Asset Value(s)
18th Dec 201911:25 amRNSNet Asset Value(s)
17th Dec 201910:47 amRNSNet Asset Value(s)
16th Dec 20194:26 pmRNSTransaction in Own Shares
16th Dec 201912:22 pmRNSNet Asset Value(s)
13th Dec 201911:09 amRNSNet Asset Value(s)
12th Dec 201910:51 amRNSNet Asset Value(s)
11th Dec 201910:33 amRNSNet Asset Value(s)
10th Dec 201911:21 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.